Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
131M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
64.7M
-
Shares change
-
+5.8M
-
Total reported value, excl. options
-
$953M
-
Value change
-
+$74.7M
-
Put/Call ratio
-
0.81
-
Number of buys
-
90
-
Number of sells
-
-44
-
Price
-
$14.73
Significant Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2020
177 filings reported holding AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value as of Q3 2020.
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.7M shares
of 131M outstanding shares and own 49.49% of the company stock.
Largest 10 shareholders include HealthCor Management, L.P. (8.87M shares), NEA Management Company, LLC (5.17M shares), FMR LLC (4.88M shares), ORBIMED ADVISORS LLC (4.75M shares), PICTET ASSET MANAGEMENT LTD (3.76M shares), Avidity Partners Management LP (3.56M shares), CITADEL ADVISORS LLC (3.48M shares), GREAT POINT PARTNERS LLC (2.49M shares), Point72 Asset Management, L.P. (2.34M shares), and Connor, Clark & Lunn Investment Management Ltd. (1.62M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.